CommentNew antibiotic development: the need versus the costs
References (11)
- et al.
Guidelines for the management of adult lower respiratory tract infections—summary
Clin Microbiol Infect
(2011) - et al.
Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis
Am J Med
(2007) - et al.
The value of macrolide-based regimens for community-acquired pneumonia
Curr Infect Dis Rep
(2015) - et al.
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Clin Infect Dis
(2007) - et al.
Macrolide resistance in bacteremic pneumococcal disease: implications for patient management
Clin Infect Dis
(2006)
There are more references available in the full text version of this article.
Cited by (8)
Flavonoid-Decorated Nano-gold for Antimicrobial Therapy Against Gram-negative Bacteria Escherichia coli
2021, Applied Biochemistry and BiotechnologyDeveloping a hybrid antimicrobial resistance surveillance system in India: Needs & challenges
2019, Indian Journal of Medical ResearchAntibiotic Stewardship 2.0: Individualization of therapy
2017, InternistInfectiology in intensive care medicine
2017, Medizinische Klinik - Intensivmedizin und Notfallmedizin
Copyright © 2016 Elsevier Ltd. All rights reserved.